DA Barocas
Vanderbilt University Medical Center
5 Papers
10 Citations
DA Barocas is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Prostate cancer & Hypofractionated Radiation Therapy. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline
Scott C. Morgan,Karen E. Hoffman,D. Andrew Loblaw,Mark K. Buyyounouski,Mark K. Buyyounouski,Caroline Patton,DA Barocas,Søren M. Bentzen,Michael Chang,Michael Chang,Jason A. Efstathiou,Patrick Greany,Per H. Halvorsen,Bridget F. Koontz,Colleen A. Lawton,C. Marc Leyrer,Daniel W. Lin,Michael E. Ray,Howard M. Sandler +18 more
TL;DR: Hypofractionated radiation therapy provides important potential advantages in cost and convenience for patients, and these recommendations are intended to provide guidance on moderate hypofractionation and ultrahyp ofractionation for localized prostate cancer.
205
Methods for health economic evaluation
Craig R Ramsay,Robert Pickard,C Robertson,A Close,Luke Vale,Nigel Armstrong,DA Barocas,Christopher G. Eden,Christophe Fraser,Tara Gurung,D Jenkinson,X Jia,Thomas B Lam,Graham Mowatt,David E. Neal,Max Robinson,J Royle,Steve P. Rushton,Pawana Sharma,Mdf Shirley,Naeem Soomro +20 more
- 01 Nov 2012
10
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment
Yu Jiang,Travis J. Meyers,Adaeze A. Emeka,Lauren Folgosa Cooley,Phillip R. Cooper,Nicola Lancki,Irene Helenowski,Linda Kachuri,Daniel W. Lin,Daniel W. Lin,Janet L. Stanford,Janet L. Stanford,Lisa F. Newcomb,Lisa F. Newcomb,Suzanne Kolb,Suzanne Kolb,Antonio Finelli,Neil E. Fleshner,Maria Komisarenko,James A. Eastham,Behfar Ehdaie,Nicole Benfante,Christopher J. Logothetis,Justin R. Gregg,Cherie Perez,Sergio Garza,Jeri Kim,Leonard S. Marks,Merdie Delfin,Danielle Barsa,Danny Vesprini,Laurence Klotz,Andrew Loblaw,Alexandre Mamedov,S. Larry Goldenberg,Celestia S. Higano,Maria Spillane,Eugenia Wu,H. Ballentine Carter,Christian P. Pavlovich,Mufaddal Mamawala,Tricia Landis,Peter R. Carroll,June M. Chan,Matthew R. Cooperberg,Janet E. Cowan,Todd M. Morgan,Javed Siddiqui,Rabia Martin,Eric A. Klein,Karen Brittain,Paige Gotwald,DA Barocas,Jeremiah R. Dallmer,Jeremiah R. Dallmer,Jennifer B. Gordetsky,Pam Steele,Shilajit Kundu,Jazmine Stockdale,Monique J. Roobol,Lionne D.F. Venderbos,Martin G. Sanda,Rebecca S. Arnold,Dattatraya Patil,Christopher P. Evans,Marc A. Dall'Era,Anjali Vij,Anthony J. Costello,Ken Chow,Niall M. Corcoran,Soroush Rais-Bahrami,Courtney Phares,Douglas S. Scherr,Thomas Flynn,R. Jeffrey Karnes,Michael O. Koch,Courtney Rose Dhondt,Joel B. Nelson,Dawn McBride,Michael S. Cookson,Kelly L. Stratton,Stephen Farriester,Erin Hemken,Walter M. Stadler,Tuula Pera,Deimante Banionyte,Fernando J. Bianco,Isabel H. Lopez,Stacy Loeb,Samir S. Taneja,Nataliya Byrne,Christopher L. Amling,Ann Martinez,Luc Boileau,Franklin Gaylis,Jacqueline Petkewicz,Nicholas Kirwen,Brian T. Helfand,Jianfeng Xu,Denise M. Scholtens,William J. Catalona,John S. Witte +101 more
TL;DR: In this article, a multi-institutional genome-wide association study (GWAS) of 6,361 PC patients who initially elected active surveillance and were followed over time for the potential outcome of conversion from AS to active treatment was conducted.
7
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.
Scott C. Morgan,Karen E. Hoffman,D. Andrew Loblaw,Mark K. Buyyounouski,Mark K. Buyyounouski,Caroline Patton,DA Barocas,Søren M. Bentzen,Michael Chang,Jason A. Efstathiou,Patrick Greany,Per H. Halvorsen,Bridget F. Koontz,Colleen A. Lawton,C. Marc Leyrer,Daniel W. Lin,Michael E. Ray,Howard M. Sandler +17 more
TL;DR: Recommendations are intended to provide guidance on moderate hypofractionation and ultrahyp ofractionation for localized prostate cancer and highlight the imperative to support large-scale randomized clinical trials and underscore the importance of shared decision making between clinicians and patients.